SCHEMBL7936336

SCHEMBL7936336

COC(=O)c1ccc(C#CCc2ccc3c(c2)C(C)(C)CCC3)cc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.37
PDK4 Q16654 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
RXRA P19793 2/20 0.36
RXRB P28702 2/20 0.36
RXRG P48443 2/20 0.36
GAA P10253 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.34
EGFR P00533 1/20 0.34
PTPN11 Q06124 1/20 0.33
CYP3A4 P08684 2/20 0.33
MYC P01106 1/20 0.33
MAPT P10636 4/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7751144 0.89 RXRA (0.40) RXRARXRBRXRGCYP3A4RAB9A
SCHEMBL7752278 0.88 CYP3A4 (0.44) PDK2PDK4CA12CA1CA2
SCHEMBL7937802 0.82 RXRA (0.41) PDK2PDK4CA12CA1CA2
SCHEMBL7937368 0.82 RXRA (0.40) RXRARXRBRXRGCYP3A4RAB9A
SCHEMBL7940029 0.80 PDK2 (0.36) PDK2PDK4CA12CA1CA2
SCHEMBL7928392 0.77 RXRA (0.40) PDK2PDK4CA12CA1CA2
SCHEMBL7928435 0.76 PDK2 (0.35) PDK2PDK4CA12CA1CA2
SCHEMBL6378170 0.76 RARB (0.52) RXRARXRBRXRGCYP3A4CYP26A1
SCHEMBL7751252 0.75 CYP26A1 (0.44) RXRARXRBRXRGCYP3A4ALDH1A1
SCHEMBL6338106 0.75 RARA (0.36) PDK2PDK4CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313162-B1 FOR USE IN HUMAN OR VETERINARY MEDICINE SUCH AS DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHHALMOLOGICAL DISORDERS; AND IN COSMETICS CENTRE INTERNATIONAL DE RECHERCHE DERMATOLOGIQUES GALDERMA (C.I.R.D.) GALDERMA (FR) 2001-11-06 US disclosed
US-6046220-A ADMINISTERING TO THE PATIENT A PROPYNYL OR DIENYL BIAROMATIC COMPOUND TO TREAT A SKIN DISORDER, INFLAMMATORY CONDITIONS, VISION DEFECTS, ALOPECIA, CARDIOVASCULAR DISORDER, CANCER OR PRECANCER AND INSULIN DEPENDANT DIABETES CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-04-04 US disclosed